Doctors track Real-World use of Heart-Lung drug in critically ill newborns
NCT ID NCT06499363
Summary
This study aims to gather real-world information on how the drug treprostinil is used to treat newborns with persistent pulmonary hypertension, a serious condition where blood pressure is too high in the lungs. Researchers will observe 60 infants in France who are already receiving this medication as part of their standard care. The goal is to better understand the drug's safety, how it's given, and how well it works in everyday hospital practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT PULMONARY HYPERTENSION OF NEWBORN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Lille - Clinique de Néonatalogie
RECRUITINGLille, 59000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU Lyon (HCL) - Hopital Femme Mère Enfant
RECRUITINGBron, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Toulouse Hopital des enfants - Réanimation Néonatale
RECRUITINGToulouse, 31300, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Réanimation néonatale CHU Grenoble Alpes - Hôpital Couple Enfant
RECRUITINGGrenoble, 38043, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.